KRAS and adenocarcinoma: Interestingly, KRAS mutation status in healthy controls was positively associated with patient age, indicating a potential for detecting KRAS mutations in the premalignant stages of PDAC or an alternative malignancy also associated with KRAS mutagenesis, such as other adenocarcinomas of the lung or colon [23,67,68].